Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

GBIO - Generation Bio Co


IEX Last Trade
2.64
-0.040   -1.515%

Share volume: 55,239
Last Updated: Fri 30 Aug 2024 09:59:55 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology): 0.21%

PREVIOUS CLOSE
CHG
CHG%

$2.68
-0.04
-1.49%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
4%
Profitability 0%
Dept financing 0%
Liquidity 0%
Performance 10%
Performance
5 Days
-0.38%
1 Month
-18.52%
3 Months
-18.77%
6 Months
2.72%
1 Year
-47.51%
2 Year
-49.52%
Key data
Stock price
$2.64
P/E Ratio 
0.00
DAY RANGE
N/A - N/A
EPS 
$0.00
52 WEEK RANGE
$0.86 - $5.09
52 WEEK CHANGE
-$0.48
MARKET CAP 
176.197 M
YIELD 
N/A
SHARES OUTSTANDING 
66.741 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/07/2024
BETA 
3.44
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$75,454
AVERAGE 30 VOLUME 
$78,183
Company detail
CEO:
Region: US
Website: generationbio.com
Employees: 176
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services

generation bio is creating a revolutionary new class of genetic medicines that deliver durable, high levels of gene expression and have drug-like properties, including ability to titrate to effect and re-dose. our unique genewave technology allows us to overcome the limitations of other approaches by delivering larger genes, including more sophisticated regulatory elements, and avoiding the immunogenicity which limits both the number of patients who can be treated and the ability to re-dose them over time. we are a community of creative problem-solvers and independent thinkers. we are guided by strong personal integrity, humility, and the collaborative, learning mindset required to create solutions for patients and their families. to learn more about our efforts to usher in a new generation in medicine, please visit www.generationbio.com or our twitter feed, @lifetimegenetx.

Recent news